Showing results (1101-1110 of 1,324) with videos related to
Sort By:
Pageof 133
International Journal of Cancer|November 10, 2018
New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinomaVincent Chin-Hung Chen, Hsiang-Lin Chan, Tsai-Ching Hsu, et al.Environmental Health Perspectives|March 29, 2019
Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley RatsJustin M Conley, Christy S Lambright, Nicola Evans, et al.Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|September 17, 2015
Religious coping and its influence on psychological distress, medication adherence, and quality of life in inflammatory bowel diseaseThiago H Freitas, Thomas N Hyphantis, Elias Andreoulakis, et al.British Journal of Pharmacology|July 1, 2008
Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig modelX Yao, D L Anderson, S A Ross, et al.Expert Opinion on Investigational Drugs|April 25, 2023
Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trialsGia Han Le, Emily S Gillissie, Taeho Greg Rhee, et al.Acta Neuropsychiatrica|February 14, 2025
Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic reviewHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Expert Review of Neurotherapeutics|September 21, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illnessHartej Gill, Barjot Gill, David Chen-Li, et al.Journal of Pain and Symptom Management|April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced CancerStefan Aguiar, Mary Makarious, Orly Lipsitz, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 27, 2018
Is binge eating a cognitive disorder? Results from the International Mood Disorders Collaborative ProjectYena Lee, Nicole E Carmona, Margarita Shekotikhina, et al.Expert Opinion on Drug Safety|June 17, 2020
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellenceNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.Pageof 133